The landscape of technological devices is changing at an unprecedented pace from having limited access to CGM and poor awareness of insulin pump therapy only a few years ago to today where there is an unprecedented expansion in access to CGM and the dawn of Hybrid closed-loop ‘artificial pancreas’ systems.
To keep up to date with this fast pace, a new initiative Diabetes Technology Network (Ireland), was launched by Consultant Endocrinologists Hannah Forde (Beaumont Hospital, Dublin) and Tomás Griffin (University Hospital Galway) and supported by Diabetes Ireland.
The long-term goal is to make diabetes technology accessible for all people who need it to manage diabetes in Ireland and to have ongoing support from your local diabetes team.
To achieve this, DTN Ireland looks to raise awareness, inform and educate people with diabetes about the benefits of diabetes technology and encourage diabetes specialists to provide access to technology through their clinics.
Diabetes Technology Network Ireland essentially aims to:
- be the voice and advocate for better diabetes technology utilisation and uptake for people living with diabetes in Ireland and working with the relevant stakeholders to increase access to technologies in Ireland;
- learn from the best international guidance and expertise and share best practices with diabetes specialists across the country through guidance documents/pathways on diabetes technology development;
- support healthcare professionals in the delivery of technologies designed to improve the lives of people living with diabetes and their families, by delivering practical education to healthcare professionals on diabetes technology utilisation.